CompanyLABNasdaqBoston, MA

Standard Biotools Inc.

Standard BioTools develops next-generation life science research tools and solutions for biomedical researchers.

SEC EDGAR ClinicalTrials.gov standardbio.com

8-KSep 30Latest SEC filing

Sep 30Latest story

September 2026

Standard BioTools switches mass cytometry buyer to GMT Venture unit, ends Multiplex Bio deal

Sep 30PartnershipStandard Biotools Inc.

August 2026

Standard BioTools reports Q2 2026 results, says Treeline merger on track to close by year-end

Aug 5Quarterly updateStandard Biotools Inc.

July 2026

Standard BioTools agrees to sell Mass Cytometry unit, gets $30M Illumina payout

Jul 28M&AStandard Biotools Inc.